Drugs Made In America Acquisition II Corp. (DMII, DMIIR, DMIIU)
CIK 2040475 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Drugs Made In America Acquisition II Corp..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 14, 2026 | 10-Q | 0001213900-26-090017 |
| May 14, 2026 | 10-Q | 0001213900-26-056651 |
| Apr 28, 2026 | 8-K | 0001213900-26-048687 |
| Apr 15, 2026 | 10-K | 0001213900-26-044055 |
| Apr 3, 2026 | 8-K | 0001213900-26-039986 |
| Apr 1, 2026 | NT 10-K | 0001213900-26-038498 |
| Mar 17, 2026 | 8-K | 0001213900-26-029050 |
| Mar 6, 2026 | 8-K | 0001213900-26-024763 |
| Mar 6, 2026 | 8-K | 0001213900-26-024387 |
| Nov 18, 2025 | 10-Q | 0001213900-25-112095 |
| Nov 18, 2025 | 8-K | 0001213900-25-111706 |
| Nov 17, 2025 | NT 10-Q | 0001213900-25-111209 |
| Oct 17, 2025 | 4 | 0001213900-25-099838 |
| Oct 2, 2025 | 8-K | 0001213900-25-095513 |
| Oct 2, 2025 | SCHEDULE 13D | 0001213900-25-094944 |
| Oct 2, 2025 | 4 | 0001213900-25-095291 |
| Oct 1, 2025 | 4 | 0001213900-25-094436 |
| Oct 1, 2025 | 4 | 0001213900-25-094430 |
| Oct 1, 2025 | 4 | 0001213900-25-094427 |
| Oct 1, 2025 | 4 | 0001213900-25-094676 |
| Sep 29, 2025 | 8-K | 0001213900-25-093224 |
| Sep 25, 2025 | 424B4 | 0001213900-25-091724 |
| Sep 25, 2025 | 3 | 0001213900-25-091842 |
| Sep 24, 2025 | 8-A12B | 0001213900-25-091080 |
| Sep 24, 2025 | 3 | 0001213900-25-091250 |